Luteolin Protects Against Noise‐Induced Hearing Loss via Mitigating Oxidative Stress and Apoptosis, With Potential Regulation of the EGR1 / SPRY4 Axis
CNS Neuroscience & Therapeutics · 2026-05 · 32 (5)
DOI: 10.1002/cns.70906 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 01.05.2026. Verfasst von Jia-Ning Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Tangdu Hospital, Air Force Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Apoptosis, Oxidative Stress, Luteolin, Hearing Loss, Noise-Induced. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
Noise‐induced hearing loss (NIHL) is a globally prevalent disorder caused by oxidative stress‐mediated hair cell death, with no effective clinical treatments. This study explored the protective effect of luteolin (LL), a natural antioxidant flavonoid, against NIHL and its underlying molecular mechanism.
Methods
In vivo, mice received intratympanic LL injections around noise exposure, followed by ABR testing and cochlear immunofluorescence staining. In vitro, cochlear explants and HEI‐OC1 cells were pretreated with LL, followed by the induction of oxidative stress using tert‐butyl hydroperoxide (TBHP). Cellular viability, oxidative stress, and apoptosis were assessed. CRISPR/Cas9 technique was used to establish an Early growth response 1 (EGR1) knockout cell line. ChIP‐PCR and dual‐luciferase reporter assays clarified molecular mechanisms.
Results
Intratympanic LL significantly attenuated noise‐induced auditory threshold elevation and outer hair cell loss in mice without affecting normal hearing. In vitro, LL dose‐dependently mitigated TBHP‐induced damage via regulating oxidative stress and apoptotic pathways, reversed TBHP‐induced EGR1 upregulation, EGR1 knockout enhanced oxidative stress resistance, and EGR1 directly regulated sprouty RTK signaling antagonist 4 (SPRY4) transcription, while LL inhibited TBHP‐induced SPRY4 upregulation.
Conclusion
Luteolin protects against NIHL by alleviating oxidative stress and suppressing apoptosis, with potential involvement of the EGR1/SPRY4 signaling axis, representing a promising candidate for NIHL prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology Head and Neck Surgery, Tangdu Hospital, Air Force Medical University, Xi'an, China.
- Department of Otolaryngology Head and Neck Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China.
ORCID-Profile: Peng-Wei Ma, Jia-Wei Chen, Wei Gao, Lian-Jun Lu
Förderung
- the National Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Guo, J. N., Mei, H. K., Liang, R., Ma, P. W., Wang, W. L., Chen, J. W., Wang, Z., Yuan, H., Lun, Y. Q., Gao, W., & Lu, L. J. (2026). Luteolin Protects Against Noise‐Induced Hearing Loss via Mitigating Oxidative Stress and Apoptosis, With Potential Regulation of the EGR1 / SPRY4 Axis. CNS Neuroscience & Therapeutics, 32(5). https://doi.org/10.1002/cns.70906
Vancouver
Guo JN, Mei HK, Liang R, Ma PW, Wang WL, Chen JW, et al. Luteolin Protects Against Noise‐Induced Hearing Loss via Mitigating Oxidative Stress and Apoptosis, With Potential Regulation of the EGR1 / SPRY4 Axis. CNS Neuroscience & Therapeutics. 2026;32(5). doi:10.1002/cns.70906
BibTeX
@article{Guo2026,
author = {Guo, Jia-Ning and Mei, Hong-Kai and Liang, Rui and Ma, Peng-Wei and Wang, Wei-Long and Chen, Jia-Wei and Wang, Zi and Yuan, Hao and Lun, Yu-Qiang and Gao, Wei and Lu, Lian-Jun},
title = {Luteolin Protects Against Noise‐Induced Hearing Loss via Mitigating Oxidative Stress and Apoptosis, With Potential Regulation of the EGR1 / SPRY4 Axis},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {5},
doi = {10.1002/cns.70906}
}
EUVIMED